Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BRS65X63 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.60 -0.45% 133.20 133.10 133.40 134.70 131.50 131.50 728,968 16:35:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 473.2 -126.5 -14.6 - 978

Indivior Share Discussion Threads

Showing 3701 to 3724 of 3725 messages
Chat Pages: 149  148  147  146  145  144  143  142  141  140  139  138  Older
DateSubjectAuthorDiscuss
07/4/2021
10:26
aye looking positive if it breaks thru the 134.20p resistence the next might come into sight ar 149p as we move towards the beginning of May
waldron
07/4/2021
09:55
Feel that headline incorrect due to translation error from french Should haVE READ Turnround in sight Https://www.zonebourse.com/cours/action/INDIVIOR-PLC-19344116/actualite-bourse/Toujours-du-potentiel-32901100/
sarkasm
07/4/2021
08:28
Https://www.marketscreener.com/quote/stock/INDIVIOR-PLC-19344116/news-strategies/No-turn-around-in-sight-32901101/
waldron
31/3/2021
19:29
The 2021 AGM will be held on Thursday 6 May 2021 at 3.00pm.
waldron
31/3/2021
19:28
Annual Report and Notice of Annual General Meeting The Company has today posted or made available to shareholders the following documents: - Annual Report and Accounts for the year ended December 31, 2020 (the '2020 Annual Report'); - Notice of 2021 Annual General Meeting ('AGM') ; and - Form of Proxy for the AGM. In accordance with LR 9.6.1, a copy of each of these documents has been submitted to the FCA and will shortly be available for inspection at Https://data.fca.org.uk/#/nsm/nationalstoragemechanism . The 2020 Annual Report and Notice of AGM can also be viewed on the Company's website at www.indivior.com/annual-reports/ and www.indivior.com/shareholders/shareholder-communications/ . The Appendix to this announcement contains information which has been extracted from the 2020 Annual Report for purposes of compliance with the FCA's Disclosure Guidance and Transparency Rules and should be read together with the Company's Final Results announcement released on February 18, 2021. Together these constitute the material required by Disclosure Guidance and Transparency Rule 6.3.5 which is required to be communicated to the media in full unedited text through a Regulatory Information Service. This announcement is not a substitute for reading the full Annual Report and Accounts. Page numbers and cross references in the extracted information refer to page numbers and cross references in the 2020 Annual Report. AGM meeting arrangements The 2021 AGM will be held on Thursday 6 May 2021 at 3.00pm. Due to the current COVID-19 restrictions, the AGM will be held at the Company's offices with a limited number of Company representatives attending to ensure that a valid meeting is held. Other shareholders will not be permitted to attend the AGM in person and shareholders are therefore asked to appoint the Chair of the meeting as their proxy. Arrangements have been made to allow shareholders to join the meeting online, further details can be found in the Notice of Meeting. The Board understands that the AGM is an important event in the corporate calendar and is committed to returning to an open AGM format in future years when COVID-19 restrictions are eased.
waldron
25/3/2021
11:21
Review in todays Times business section commenting on Scopia appointment to board.Just a summation of recent history really.
steeplejack
24/3/2021
15:11
After all activist Share holders are only interested in total return and in this lifetime!
gregmorg
24/3/2021
10:08
Intriguing management strategic announcement. Obviously the team put together by Scopia assumes very strong cash flows from future revenues and a strategic team is being put in place to guide /direct/build. As a 16.9% shareholder and associating itself via these appointments and tie up via the future intended enhanced build up and direction of Indivior , Scopia obviously intends to enhance its shareholding over time. Enhancing acquisitions possible over time is my guess. Will it all work - we will see. I ask myself is this good news or bad news. Well, I don't see that it's bad news so I guess it must be good news! Jury will decide.
gregmorg
24/3/2021
09:16
Re Scopia move-“AND̶1;?
gregmorg
15/3/2021
13:32
perhaps next resistence at 134.20p
waldron
15/3/2021
13:30
(MT Newswires) -- S&P Global Ratings on Thursday affirmed Indivior's (INDV.L) B long-term rating, but revised the outlook to stable from negative, as it resolved major uncertainties related to litigation and performed stronger than expected in 2020. The US-based pharmaceuticals company reached a $600 million settlement with the US Department of Justice and a $50 million settlement with Reckitt Benckiser (RB.L), and its cash balance of $858 million on Dec. 31, 2020, is expected to support the payments through 2027. Meanwhile, the company's volume growth of its Sublocade injection and remaining market share of Suboxone film will generate healthy free cash flow by 2023. "We think revenue declines in recent years are likely to stabilize in 2021, and revenue should grow in 2022 and 2023," S&P said. Indivior's shares fell over 3% at the close of trading on Thursday. Price (GBP): £120.00, Change: £-3.90, Percent Change: -3.15%
waldron
15/3/2021
13:23
not sure why this has been a laggard in recent weeks. net cash position is very high, bad events behind it now.
dealy
02/3/2021
14:50
Well, I guess it’s important for directors to be incentivised and have skin in the game although I am not sure I was asked to give them some of my skin! Having said that, at least in terms of timing it tells you the executives want to be fully on board which points to a better share price future-- in theory, I accept!
gregmorg
26/2/2021
19:13
THE WISH LIST GIVING BOXES,Supports and Resistences to determine channels and trends together with broker targets which might of course make you smile or and smirk 100 to 110p 110 to 120p 120 to 130p$$$$$$$$$$$$$ WE ARE HERE $$$$$$$$$$$$$$$ 130 to 140p 140 to 150p 150 to 160p 160 to 170p 170 to 180p 180 to 190p Citi target 185p 190 to 200p Jefferies target 200p Https://www.marketscreener.com/INDIVIOR-19344116/ DECEMBER END 2019 GIVES 39p which puts us into the 30 to 40p BOX again December 2020 ends at 108.80p January 2021 ends at 137.35p
waldron
20/2/2021
09:21
[United Kingdom] INDIVIOR (INDV) Delayed Quote. Delayed London Stock Exchange - 02/19 04:35:13 pm 127.6 GBX -8.40%
waldron
20/2/2021
09:20
THE WISH LIST GIVING BOXES,Supports and Resistences to determine channels and trends together with broker targets which might of course make you smile or and smirk 100 to 110p 110 to 120p 120 to 130p$$$$$$$$$$$$$ WE ARE HERE $$$$$$$$$$$$$$$ 130 to 140p 140 to 150p 150 to 160p 160 to 170p 170 to 180p 180 to 190p Citi target 185p 190 to 200p Jefferies target 200p Https://www.marketscreener.com/INDIVIOR-19344116/ DECEMBER END 2019 GIVES 39p which puts us into the 30 to 40p BOX again December 2020 ends at 108.80p January 2021 ends at 137.35p February 2021 ends at 128.10p
waldron
19/2/2021
17:39
Slightly surprised at the weakness on the results but guess it's had a good run. Still plenty of upside imo
baddeal
18/2/2021
16:27
Proactiveinvestors Philip Whiterow 08:34 Thu 18 Feb 2021 Follow Philip on: Investor deep dive Symphony Environmental makes progress in battle against COVID-19 read more > viewIndivior PLC Indivior in red after legal settlements take toll Losses for the year were US$173mln with a US$14mln deficit in the final three months Indivior PLC - Suboxone's market share is falling rapidly Indivior PLC (LON:INDV) posted an improvement in sales in the final quarter of 2020 as Sublocade, its injectable, extended-release opioid dependency treatment, picked up momentum. The drug group is trying to build sales of Sublocade to offset a steady decline by its predecessor Suboxone, which has now come off patent. Revenues for the year to end-December fell 18% to US$647mln though there was a 39% jump in the final quarter as sales of Sublocade rose 18%. Losses for the year were US$173mln with a US$14mln deficit in the final three months. During the year, Indivior settled outstanding legal cases with the US Department of Justice and former parent Reckitt Benckiser and Indivior took one-off charges of US$244mln in the 2020 numbers. Mark Crossley, chief executive, said that given the problems related to the coronavirus pandemic he was 'delighted' with the numbers. “Critically, we materially de-risked the business with resolution of the DOJ and RB matters and we took decisive strategic alignment actions which place Indivior on a clear path towards realizing the transformational potential of Sublocade. “Accelerating the growth of Sublocade remains the biggest potential driver of value creation.“ Indivior’s base case assumptions for 2021 are for net revenues to rise to US$625mln with Sublocade net revenues of between US185mln and $210mln (2020: US$130mln).
waldron
18/2/2021
13:57
Well, the preliminary statement today appeared steady but unexciting and I am afraid it did very little for me. Nevertheless I found the upbeat webcast rather more reassuring. It gave a very positive message for the medium/ long term without a doubt. Shorter term I just don't know as I am unsure what will drive it. So with all its complexities I will await events.
gregmorg
05/2/2021
17:34
04 February 2021 Indivior to Announce FY 2020 Results and Host a Presentation on February 18(th) Slough, UK, and Richmond, VA, February 4, 2021 - Indivior PLC (LON: INDV) today announced that it will release its FY 2020 results on February 18th at 7:00 a.m. London time (2:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at www.indivior.com . Mark Crossley, Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 12:00 GMT (7:00 a.m. U.S. Eastern) on February 18th. Access to the Live Webcast Presentation The webcast event and materials can be accessed on the "Investors" section of the company's website at www.indivior.com before the event begins. The webcast link is Https://edge.media-server.com/mmc/p/23dggtiy . Participants may access the presentation telephonically : -- US participants 1-646-741-3167 -- International participants +44 (0) 2071-928338 Please reference confirmation ID 3290938. A replay of the presentation will be available at www.indivior.com .
la forge
05/2/2021
17:32
Upcoming events on INDIVIOR February/18/2021 FY 2020 Earnings Release
la forge
29/1/2021
21:40
THE WISH LIST GIVING BOXES,Supports and Resistences to determine channels and trends together with broker targets which might of course make you smile or and smirk 100 to 110p 110 to 120p 120 to 130p 130 to 140p$$$$$$$$$$$$$ WE ARE HERE $$$$$$$$$$$$$$$ 140 to 150p 150 to 160p 160 to 170p 170 to 180p 180 to 190p Citi target 185p 190 to 200p Jefferies target 200p Https://www.marketscreener.com/INDIVIOR-19344116/ DECEMBER END 2019 GIVES 39p which puts us into the 30 to 40p BOX again December 2020 ends at 108.80p January 2021 ends at 137.35p
waldron
29/1/2021
21:36
[United Kingdom] INDIVIOR (INDV) Real-time Estimate Quote. Real-time Estimate CHI-X - 01/29 04:30:00 pm 137.35 GBX +2.12%
waldron
26/1/2021
14:02
I prefer the Numis analysts view and tp......INDIVIOR (BUY, 320p) RB indemnity resolved. Indivior last night announced that it had settled with former parent Reckitt Benckiser, and will pay RB $50m over 5-years. This is clearly a welcome relief since the initial claim of $1.4bn raised concerns over the ongoing liquidity of the company. Indivior has also released RB from any indemnity claims it may have had. Indivior is now in a very strong position to build on the encouraging end to FY20 with full results expected to be published on 18-Feb. In our view, the shares remain very cheap on 5x EV/EBITDA with the prospects for the business improving significant given the expected expansion of the prescriber base given changes to prior restrictions.
baddeal
Chat Pages: 149  148  147  146  145  144  143  142  141  140  139  138  Older
ADVFN Advertorial
Your Recent History
LSE
INDV
Indivior
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210413 23:33:51